CS logo
small CS logo
Saitama Cancer Center

Kita Adachi Ina Komuro 818, Saitama, Japan
Specialized hospital in Ina
780番地 Komuro, Ina, Kitaadachi District, Saitama 362-0806

About Saitama Cancer Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
6
Haruhiko Fukuda
5
Japan Clinical Oncology Group
4
Sumitomo Pharma Oncology, Inc.
2
Eli Lilly and Company
1
Regeneron Pharmaceuticals
1
Taiho Oncology, Inc.
1
Total Rows: 7

Clinical Trials at Saitama Cancer Center


During the past decade, Saitama Cancer Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 8 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2222110000002200002200221122Started TrialsCompleted Trails20152016201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110
2002-06-01
2014-03-01
Completed
500
Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion
1999-08-01
2006-11-01
Completed
80
Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)
2003-07-01
2012-02-01
Completed
200
A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
2000-11-01
2007-01-01
Completed
690
A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC
2002-09-01
2011-09-01
Completed
281
Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)
2002-09-01
2010-02-01
Completed
300
Elderly NSCLC/D vs DP (JCOG0207)
2003-04-01
2007-04-01
Terminated
230
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
2005-11-01
2015-04-01
Completed
316

Rows per page:

1–20 of 20

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Saitama Cancer Center" #1 sponsor was "Pfizer" with 6 trials, followed by "Haruhiko Fukuda" with 5 trials sponsored, "Japan Clinical Oncology Group" with 4 trials sponsored, "Sumitomo Pharma Oncology, Inc." with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saitama Cancer Center" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 9 trials as a collaborator, "Japan Breast Cancer Research Group (JBCRG)" with 1 trials as a collaborator, "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Yakult Honsha Co., LTD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 6Pfizer: 6Haruhiko Fukuda: 5Haruhiko Fukuda: 5Japan Clinical OncologyGroup: 4Japan Clinical OncologyGroup: 4Sumitomo PharmaOncology, Inc.: 2Sumitomo PharmaOncology, Inc.: 2Eli Lilly and Company: 1Eli Lilly and Company: 1Regeneron Pharmaceuticals: 1Regeneron Pharmaceuticals: 1Taiho Oncology, Inc.: 1Taiho Oncology, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsMinistry of Health,Labour and Welfare,Japan: 9Ministry of Health,Labour and Welfare,Japan: 9Japan Breast CancerResearch Group(JBCRG): 1Japan Breast CancerResearch Group(JBCRG): 1Taiho PharmaceuticalCo., Ltd.: 1Taiho PharmaceuticalCo., Ltd.: 1Yakult Honsha Co., LTD: 1Yakult Honsha Co., LTD: 1

Clinical Trials Conditions at Saitama Cancer Center


According to Clinical.Site data, the most researched conditions in "Saitama Cancer Center" are "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Colorectal Cancer" (2 trials), "Gastric Cancer" (2 trials) and "Gastric Neoplasm" (2 trials). Many other conditions were trialed in "Saitama Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Saitama Cancer Center


Most popular intervention types in "Saitama Cancer Center" are "Drug" (18 trials), "Procedure" (4 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "PD-0332991" (2 trials), "Paclitaxel" (2 trials), "A: Radiotherapy alone" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Saitama Cancer Center


The vast majority of trials in "Saitama Cancer Center" are 15 trials for "All" genders and 5 trials for "Female" genders.

Clinical Trials Status at Saitama Cancer Center


Currently, there are NaN active trials in "Saitama Cancer Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Saitama Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Saitama Cancer Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 16Phase 3: 16Phase 2: 2Phase 2: 2Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 14Completed: 14Active, not recruiting: 3Active, not recruiting: 3Terminated: 2Terminated: 2Recruiting: 1Recruiting: 1

Departments of Saitama Cancer Center


Saitama Cancer Center has several departments that took part in Clinical trials: "Hyogo Brain and Heart Center" - 8 trials, "Kondo Clinic for Rheumatism and Orthopaedics" - 5 trials, "Urology department Kuroda Clinic" - 2 trials